Amneal Pharmaceuticals (AMRX) Tops Q2 EPS by 3c, Revenues Beat; Maintains FY20 EPS/Revenue Guidance
Go back to Amneal Pharmaceuticals (AMRX) Tops Q2 EPS by 3c, Revenues Beat; Maintains FY20 EPS/Revenue Guidance| AmerElite Solutions, Inc. New (NASDAQ: AMRX) | Delayed: 14.67 +0.96 (7.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.71 | 52 Week High | $0.19 | |||
| Open | $13.90 | 52 Week Low | $0.07 | |||
| Day High | $14.70 | P/E | N/A | |||
| Day Low | $13.79 | EPS | $-0.01 | |||
| Volume | 1,390,784 | |||||
